-+ 0.00%
-+ 0.00%
-+ 0.00%

Foghorn Therapeutics shareholders elect directors at annual meeting

PUBT·06/24/2026 20:02:04
Listen to the news
Foghorn Therapeutics shareholders elect directors at annual meeting
  • Foghorn Therapeutics held its annual shareholder meeting on June 24, 2026.
  • Shareholders selected Douglas Cole, Balkrishan (Simba) Gill, and B. Lynne Parshall to the board.
  • Deloitte & Touche was ratified as independent registered public accounting firm for fiscal 2026.
  • Advisory vote set an annual cadence for future votes on executive pay.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Foghorn Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-045154), on June 24, 2026, and is solely responsible for the information contained therein.